BACKGROUND: Patients with head and neck cancer experience complex posttreatment challenges. In a preliminary uncontrolled study, we evaluated the extent to which they can benefit from an interdisciplinary rehabilitation program. METHODS: Twenty-seven patients completed an 8-week nutrition-rehabilitation program. Six-minute walk distance (6MWD), body weight, symptom burden, distress, and quality of life were assessed at baseline and at the end of the program. RESULTS: Patients improved their mean 6MWD by 59 m (effect size = 0.8), and 78% of patients either maintained or increased their body weight. They also reported a clinically meaningful reduction in severity of insomnia, pain, weakness, anorexia, shortness of breath, depression and distress, and improvement in quality of life (effect sizes = 0.6-0.9). However, they reported no change in symptom interference with function. CONCLUSION: An interdisciplinary rehabilitation program may be beneficial to patients with head and neck cancer after treatment, but its effects should be evaluated in a controlled trial.
BACKGROUND:Patients with head and neck cancer experience complex posttreatment challenges. In a preliminary uncontrolled study, we evaluated the extent to which they can benefit from an interdisciplinary rehabilitation program. METHODS: Twenty-seven patients completed an 8-week nutrition-rehabilitation program. Six-minute walk distance (6MWD), body weight, symptom burden, distress, and quality of life were assessed at baseline and at the end of the program. RESULTS:Patients improved their mean 6MWD by 59 m (effect size = 0.8), and 78% of patients either maintained or increased their body weight. They also reported a clinically meaningful reduction in severity of insomnia, pain, weakness, anorexia, shortness of breath, depression and distress, and improvement in quality of life (effect sizes = 0.6-0.9). However, they reported no change in symptom interference with function. CONCLUSION: An interdisciplinary rehabilitation program may be beneficial to patients with head and neck cancer after treatment, but its effects should be evaluated in a controlled trial.
Authors: Lauren C Capozzi; Kevin R Boldt; Harold Lau; Lisa Shirt; Barry Bultz; S Nicole Culos-Reed Journal: Support Care Cancer Date: 2014-09-27 Impact factor: 3.603
Authors: Marianne Boll Kristensen; Tina Broby Mikkelsen; Anne Marie Beck; Ann-Dorthe Zwisler; Irene Wessel; Karin B Dieperink Journal: J Cancer Surviv Date: 2019-08-24 Impact factor: 4.442
Authors: B Gagnon; J Murphy; M Eades; J Lemoignan; M Jelowicki; S Carney; S Amdouni; P Di Dio; M Chasen; N Macdonald Journal: Curr Oncol Date: 2013-12 Impact factor: 3.677
Authors: Sara McEwen; Ana Maria Rodriguez; Rosemary Martino; Ian Poon; Colleen Dunphy; Jorge Norman Rios; Jolie Ringash Journal: Support Care Cancer Date: 2015-11-18 Impact factor: 3.603